Royal Bank Of Canada Gossamer Bio, Inc. Transaction History

Royal Bank Of Canada

$479 Billion
Q4 2024

A detailed history of Royal Bank Of Canada transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 1,505 shares of GOSS stock, worth $2,107. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,505

Previous 3,351 55.09%

Holding current value

$2,107

Previous $3,000 66.67%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.66 - $1.07 $1,218 - $1,975	-1,846 Reduced 55.09%	1,505 $1,000
Q3 2024 Nov 14, 2024	SELL	$0.79 - $1.25 $206 - $327	-262 Reduced 7.25%	3,351 $3,000
Q2 2024 Aug 14, 2024	BUY	$0.51 - $1.27 $236 - $588	463 Added 14.7%	3,613 $3,000
Q1 2024 Nov 05, 2024	SELL	$0.8 - $1.51 $370 - $699	-463 Reduced 12.81%	3,150 $3,000
Q1 2024 May 15, 2024	SELL	$0.8 - $1.51 $52 - $99	-66 Reduced 2.05%	3,150 $3,000
Q4 2023 Feb 14, 2024	BUY	$0.48 - $1.08 $31 - $71	66 Added 2.1%	3,216 $2,000
Q3 2023 Nov 14, 2023	SELL	$0.78 - $1.82 $167 - $391	-215 Reduced 6.39%	3,150 $2,000
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.53 $8,003 - $12,495	-8,167 Reduced 70.82%	3,365 $4,000
Q1 2023 May 15, 2023	SELL	$0.96 - $2.92 $5,485 - $16,684	-5,714 Reduced 33.13%	11,532 $14,000
Q4 2022 Feb 14, 2023	BUY	$1.74 - $12.87 $27,180 - $201,042	15,621 Added 961.29%	17,246 $37,000
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $8,039 - $16,591	1,115 Added 218.63%	1,625 $19,000
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $39,413 - $65,821	-6,602 Reduced 92.83%	510 $4,000
Q1 2022 May 16, 2022	SELL	$8.44 - $12.49 $38,300 - $56,679	-4,538 Reduced 38.95%	7,112 $61,000
Q4 2021 Feb 14, 2022	BUY	$10.12 - $14.07 $58,928 - $81,929	5,823 Added 99.93%	11,650 $132,000
Q3 2021 Nov 15, 2021	SELL	$7.25 - $13.23 $377,384 - $688,661	-52,053 Reduced 89.93%	5,827 $73,000
Q2 2021 Aug 16, 2021	BUY	$8.0 - $9.75 $463,040 - $564,330	57,880 New	57,880 $470,000

Others Institutions Holding GOSS

# of Institutions

116

Shares Held

163M

Call Options Held

821K

Put Options Held

557K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $132M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Gossamer Bio, Inc. Transaction History